PharmaCyte Biotech Inc (PMCB)
2.10
-0.01
(-0.47%)
USD |
NASDAQ |
Apr 16, 10:17
PharmaCyte Biotech Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| October 31, 2012 | -6.09K% |
| July 31, 2012 | -7.70K% |
| April 30, 2012 | -7.55K% |
| January 31, 2012 | -1.34K% |
| October 31, 2011 | -2.20K% |
| July 31, 2011 | -3.47K% |
| April 30, 2011 | -2.14K% |
| January 31, 2011 | -387.5% |
| October 31, 2010 | -288.7% |
| July 31, 2010 | -498.0% |
| April 30, 2010 | -5.47K% |
| January 31, 2010 | -2.57K% |
| October 31, 2009 | -733.0% |
| July 31, 2009 | -1.22K% |
| April 30, 2009 | -7.13K% |
| January 31, 2009 | -667.8% |
| October 31, 2008 | -211.5% |
| Date | Value |
|---|---|
| July 31, 2008 | -171.8% |
| April 30, 2008 | -460.4% |
| January 31, 2008 | -304.8% |
| October 31, 2007 | -270.7% |
| July 31, 2007 | -279.3% |
| April 30, 2007 | -184.9% |
| January 31, 2007 | -931.1% |
| October 31, 2006 | -318.5% |
| July 31, 2006 | -298.4% |
| April 30, 2006 | -1.27K% |
| January 31, 2006 | -628.0% |
| October 31, 2005 | |
| July 31, 2005 | |
| April 30, 2005 | |
| January 31, 2005 | |
| October 31, 2004 | |
| July 31, 2004 | -1.99K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | -19.35K% |
| IGC Pharma Inc | -2.74K% |
| NovaBay Pharmaceuticals Inc | -110.2% |
| Protalix BioTherapeutics Inc | -57.64% |